However, long-term effects and safety continue to be an area of research
As such, some results were felt to be inaccurate with patients on GLP-1 RA therapy for very short durations being seen to continue to lose weight after cessation
It is further alleged the manufacturer put profits over patients as they received reports of adverse events related to the use of Ozempic but failed to update labeling or recall the medication
The lawsuit, filed Wednesday in Louisiana, focuses on gastroparesis, a severe form of delayed gastric emptying, described by the National Institute of Diabetes and Digestive and Kidney Diseases as a "disorder that slows or stops the movement of food from your stomach to your small intestine." Diabetes is a known cause of gastroparesis, responsible for almost one-third of cases
For most people, this is entirely beneficial
Simultaneously, the medication signals your brain's satiety center to reduce hunger drive and food cravings, creating a dual mechanism that naturally lowers calorie intake without willpower alone